dHACM (MiMedx)

N/A

Report date: 2026/03/30 20:02:02

Base Information

Drug NamedHACM (MiMedx)
Drug Alias NameDehydrated human amnion/chorion allograftDehydrated human amniotic membrane micronisedMicronised dehydrated human amniotic membraneHuman amniotic membrane allograft - MiMedixMicronized dHACM +[12] 
ClassificationBiologics
Mechanisms of ActionCell replacementsTissue replacementsCells stimulants
TargetsNot applicable
Therapy Area/IndicationsIschemiaErectile DysfunctionTendinopathy +[8] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesMimedx Group Inc
China Registration ClassN/A

Develop Information

Active CompaniesCleveland ClinicMimedx Group IncUniversity Of Miami
Inactive CompaniesN/A
Active IndicationsIschemiaErectile DysfunctionTendinopathy +[8] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A